Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB09188ExperimentalSmall molecule
Amedalin is a selective norepinephrine reuptake inhibitor developed in the 1970s. It has no significant effect on reuptake of serotonin and dopamine and no antihistamine or anticholinergic properties. This drug...
- Formula / weight
- C19H22N2O ยท 294.398 g/mol (avg)
- Code names
- UK-3540-1
Resolves to
Structure
InChIKey
HBGWAZBZXJBYQD-IBGZPJMESA-NSMILESCNCCC[C@]1(C)C(=O)N(C2=CC=CC=C12)C1=CC=CC=C1Which companies are running trials of Amedalin, in which indications and phases, and which of those programs are still active?